Treatment of shock lung.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011175:Positive-Pressure Respiration; D011654:Pulmonary Edema / Q000209:etiology / Q000628:therapy*; D012709:Serum Albumin / Q000627:therapeutic use; D012769:Shock / Q000150:complications*; D012770:Shock, Cardiogenic / Q000150:complications; D012772:Shock, Septic / Q000150:complications; D012774:Shock, Traumatic / Q000150:complications
D003911:Dextrans; D012709:Serum Albumin; D005665:Furosemide; D003907:Dexamethasone; D004976:Ethacrynic Acid; D010100:Oxygen; D006854:Hydrocortisone; D008775:Methylprednisolone